poisar

Stocks · News reference

This Rollins Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

BenzingaAvi Kapoor

Top Wall Street analysts changed outlook on top names. See all rating changes on our analyst ratings page. ROL downgraded and price target cut.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncDelveinsight

    Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

    The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

  2. Zacks Investment ResearchNa

    PATH's 21% Rise in Million-Dollar Customers is the Number to Watch

    UiPath's million-dollar customer base grew 21% to 387 customers, significantly outpacing the 10% growth in its broader $100,000+ ARR customer segment. This indicates deeper enterprise penetration and stronger adoption of automation solutions. However, UiPath faces intensifying competition from Pegasystems and ServiceNow as enterprise demand for AI and workflow automation expands.